174 related articles for article (PubMed ID: 38308137)
1. Mitochondrial-Targeted CS@KET/P780 Nanoplatform for Site-Specific Delivery and High-Efficiency Cancer Immunotherapy in Hepatocellular Carcinoma.
Liu S; Tian H; Ming H; Zhang T; Gao Y; Liu R; Chen L; Yang C; Nice EC; Huang C; Bao J; Gao W; Shi Z
Adv Sci (Weinh); 2024 Apr; 11(14):e2308027. PubMed ID: 38308137
[TBL] [Abstract][Full Text] [Related]
2. Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma.
Xu J; Zheng Q; Cheng X; Hu S; Zhang C; Zhou X; Sun P; Wang W; Su Z; Zou T; Song Z; Xia Y; Yi X; Gao Y
J Nanobiotechnology; 2021 Oct; 19(1):355. PubMed ID: 34717654
[TBL] [Abstract][Full Text] [Related]
3. Self-heating mitochondrion-induced free radical blast for immunogenic cell death stimulation and HCC immunotherapy.
Peng M; Dong H; Shao M; Zhang X; Sun J; Ding C; Han X; Yang Q; Sang X; Cao G
J Control Release; 2024 Feb; 366():694-711. PubMed ID: 38228273
[TBL] [Abstract][Full Text] [Related]
4. Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinoma.
Chen Y; Chen HN; Wang K; Zhang L; Huang Z; Liu J; Zhang Z; Luo M; Lei Y; Peng Y; Zhou ZG; Wei Y; Huang C
J Hepatol; 2019 Jan; 70(1):66-77. PubMed ID: 30287340
[TBL] [Abstract][Full Text] [Related]
5. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
Xing R; Gao J; Cui Q; Wang Q
Front Immunol; 2021; 12():783236. PubMed ID: 34899747
[TBL] [Abstract][Full Text] [Related]
6. Bio-responsive Au-miR-183 inhibitor enhances immunotherapy in hepatocellular carcinoma by inducing immunogenic cell death.
Yin L; Wei Y; Liu Y; Mo X; Song J; Cai W
J Control Release; 2024 Apr; 368():498-517. PubMed ID: 38428529
[TBL] [Abstract][Full Text] [Related]
7. Hydrazide-manganese coordinated multifunctional nanoplatform for potentiating immunotherapy in hepatocellular carcinoma.
Hou G; Qian J; Guo M; Xu W; Wang J; Wang Y; Suo A
J Colloid Interface Sci; 2022 Dec; 628(Pt B):968-983. PubMed ID: 36037718
[TBL] [Abstract][Full Text] [Related]
8. Carrier-Free Nanoplatform via Evoking Pyroptosis and Immune Response against Breast Cancer.
Li L; Tian H; Zhang Z; Ding N; He K; Lu S; Liu R; Wu P; Wang Y; He B; Luo M; Peng P; Yang M; Nice EC; Huang C; Xie N; Wang D; Gao W
ACS Appl Mater Interfaces; 2023 Jan; 15(1):452-468. PubMed ID: 36538368
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional Novel Nanoplatform for Effective Synergistic Chemo-Photodynamic Therapy of Breast Cancer by Enhancing DNA Damage and Disruptions of Its Reparation.
Huang Z; Xian T; Meng X; Hu H; Gao L; Huang J; Yang D; Ou K; Wang B; Zhang Y
Molecules; 2023 Oct; 28(19):. PubMed ID: 37836815
[TBL] [Abstract][Full Text] [Related]
10. An Ellagic Acid Coordinated Copper-Based Nanoplatform for Efficiently Overcoming Cancer Chemoresistance by Cuproptosis and Synergistic Inhibition of Cancer Cell Stemness.
Lu S; Tian H; Li B; Li L; Jiang H; Gao Y; Zheng L; Huang C; Zhou Y; Du Z; Xu J
Small; 2024 Apr; 20(17):e2309215. PubMed ID: 38044295
[TBL] [Abstract][Full Text] [Related]
11. Tumor-Targeting NHC-Au(I) Complex Induces Immunogenic Cell Death in Hepatocellular Carcinoma.
Yang Z; Bian M; Lv L; Chang X; Wen Z; Li F; Lu Y; Liu W
J Med Chem; 2023 Mar; 66(6):3934-3952. PubMed ID: 36827091
[TBL] [Abstract][Full Text] [Related]
12. Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and hepatocellular carcinoma.
Guo J; Yu Z; Sun D; Zou Y; Liu Y; Huang L
Mol Cancer; 2021 Jan; 20(1):10. PubMed ID: 33407548
[TBL] [Abstract][Full Text] [Related]
13. Iridium Complex-Loaded Sorafenib Nanocomposites for Synergistic Chemo-photodynamic Therapy of Hepatocellular Carcinoma.
Abuduwaili W; Wang X; Huang AT; Sun JL; Xu RC; Zhang GC; Liu ZY; Wang F; Zhu CF; Liu TT; Dong L; Zhu JM; Weng SQ; Li Y; Shen XZ
ACS Appl Mater Interfaces; 2022 Aug; 14(33):37356-37368. PubMed ID: 35951459
[TBL] [Abstract][Full Text] [Related]
14. A novel immunogenic cell death-related genes signature for predicting prognosis, immune landscape and immunotherapy effect in hepatocellular carcinoma.
Xu G; Jiang Y; Li Y; Ge J; Xu X; Chen D; Wu J
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16261-16277. PubMed ID: 37698679
[TBL] [Abstract][Full Text] [Related]
15. Potentiality of immunotherapy against hepatocellular carcinoma.
Tsuchiya N; Sawada Y; Endo I; Uemura Y; Nakatsura T
World J Gastroenterol; 2015 Sep; 21(36):10314-26. PubMed ID: 26420958
[TBL] [Abstract][Full Text] [Related]
16. Chondroitin sulfate-based nanoparticles for enhanced chemo-photodynamic therapy overcoming multidrug resistance and lung metastasis of breast cancer.
Shi X; Yang X; Liu M; Wang R; Qiu N; Liu Y; Yang H; Ji J; Zhai G
Carbohydr Polym; 2021 Feb; 254():117459. PubMed ID: 33357918
[TBL] [Abstract][Full Text] [Related]
17. Janus Gold Nanoplatform for Synergetic Chemoradiotherapy and Computed Tomography Imaging of Hepatocellular Carcinoma.
Wang Z; Shao D; Chang Z; Lu M; Wang Y; Yue J; Yang D; Li M; Xu Q; Dong WF
ACS Nano; 2017 Dec; 11(12):12732-12741. PubMed ID: 29140684
[TBL] [Abstract][Full Text] [Related]
18. Theranostic Nanodots with Aggregation-Induced Emission Characteristic for Targeted and Image-Guided Photodynamic Therapy of Hepatocellular Carcinoma.
Gao Y; Zheng QC; Xu S; Yuan Y; Cheng X; Jiang S; Kenry ; Yu Q; Song Z; Liu B; Li M
Theranostics; 2019; 9(5):1264-1279. PubMed ID: 30867829
[TBL] [Abstract][Full Text] [Related]
19. In Silico Screening as a Tool to Prepare Drug-Drug Cocrystals of Ibrutinib-Ketoconazole: a Strategy to Enhance Their Solubility Profiles and Oral Bioavailability.
Kara DD; Bangera PD; Mehta CH; Tanvi K; Rathnanand M
AAPS PharmSciTech; 2023 Aug; 24(6):164. PubMed ID: 37552343
[TBL] [Abstract][Full Text] [Related]
20. Tumor Microenvironment ROS/pH Cascade-Responsive Supramolecular Nanoplatform with ROS Regeneration Property for Enhanced Hepatocellular Carcinoma Therapy.
Shi J; Wang Y; Wu Y; Li J; Fu C; Li Y; Xie X; Fan X; Hu Y; Hu C; Zhang J
ACS Appl Mater Interfaces; 2024 Feb; 16(6):7576-7592. PubMed ID: 38316581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
